This page lists the SEC filings reported by KINGDON CAPITAL MANAGEMENT, L.L.C..
| Type | Filed | Filer | Subject | Shares Owned | Percent Owned | |
|---|---|---|---|---|---|---|
| SC 13G | 2024-04-15 | KINGDON CAPITAL MANAGEMENT, L.L.C. | CURIS INC | 345,730 | 5.9% | EDGAR |
| SC 13G/A | 2024-02-06 | KINGDON CAPITAL MANAGEMENT, L.L.C. | Applied Minerals, Inc. | 21,265,377 | 5.0% | EDGAR |
| SC 13G/A | 2024-02-06 | KINGDON CAPITAL MANAGEMENT, L.L.C. | Praxis Precision Medicines, Inc. | 346,665 | 2.9% | EDGAR |
| SC 13G/A | 2023-11-29 | KINGDON CAPITAL MANAGEMENT, L.L.C. | SCYNEXIS INC | 2,237,048 | 6.0% | EDGAR |
| SC 13G | 2023-04-13 | KINGDON CAPITAL MANAGEMENT, L.L.C. | SCYNEXIS INC | 1,697,048 | 5.1% | EDGAR |
| SC 13G/A | 2023-02-06 | KINGDON CAPITAL MANAGEMENT, L.L.C. | Applied Minerals, Inc. | 30,906,049 | 7.0% | EDGAR |
| SC 13G | 2023-01-25 | KINGDON CAPITAL MANAGEMENT, L.L.C. | Praxis Precision Medicines, Inc. | 2,855,989 | 6.1% | EDGAR |
| SC 13G/A | 2022-02-10 | KINGDON CAPITAL MANAGEMENT, L.L.C. | Applied Minerals, Inc. | 20,969,195 | 9.3% | EDGAR |
| SC 13G | 2021-01-11 | KINGDON CAPITAL MANAGEMENT, L.L.C. | Applied Minerals, Inc. | 20,565,027 | 10.5% | EDGAR |
| SC 13G/A | 2020-02-10 | KINGDON CAPITAL MANAGEMENT, L.L.C. | Jaguar Health, Inc. | 270 | 0.0% | EDGAR |
| SC 13G/A | 2020-02-10 | KINGDON CAPITAL MANAGEMENT, L.L.C. | GTY Technology Holdings Inc. | 1,598,212 | 3.1% | EDGAR |
| SC 13G/A | 2020-02-10 | KINGDON CAPITAL MANAGEMENT, L.L.C. | Sesen Bio, Inc. | 4,040,835 | 3.9% | EDGAR |
| SC 13G/A | 2019-02-08 | KINGDON CAPITAL MANAGEMENT, L.L.C. | Jaguar Health, Inc. | 1,993,015 | 7.1% | EDGAR |
| SC 13G/A | 2019-02-04 | KINGDON CAPITAL MANAGEMENT, L.L.C. | Sesen Bio, Inc. | 5,239,557 | 6.8% | EDGAR |
| SC 13G | 2019-02-04 | KINGDON CAPITAL MANAGEMENT, L.L.C. | GTY Technology Holdings Inc. | 1,600,000 | 7.4% | EDGAR |
| SC 13D | 2018-06-11 | KINGDON CAPITAL MANAGEMENT, L.L.C. | Applied Minerals, Inc. | 19,373,489 | 10.6% | EDGAR |
| SC 13G | 2018-04-04 | KINGDON CAPITAL MANAGEMENT, L.L.C. | Eleven Biotherapeutics, Inc. | 2,213,980 | 5.1% | EDGAR |
| SC 13G/A | 2018-04-02 | KINGDON CAPITAL MANAGEMENT, L.L.C. | AIT Therapeutics, Inc. | 400,859 | 4.8% | EDGAR |
| SC 13G/A | 2018-02-14 | KINGDON CAPITAL MANAGEMENT, L.L.C. | Great Elm Capital Group, Inc. | 1,267,030 | 5.0% | EDGAR |
| SC 13G/A | 2018-02-14 | KINGDON CAPITAL MANAGEMENT, L.L.C. | Horizon Pharma plc | 0 | 0.0% | EDGAR |
- Form 13F-HR
- The 13F-HR report is filed quarterly to report securities held by the filer that fall under the SEC's 13F rules.
- Form SC 13D/G
- Reported by persons and groups who own 5% or more of any class of a company's outstanding shares. If the ownership changes by 1% or more, an amendment must be filed.
- Form 3, 4, and 5
- Form 3, 4, and 5 reports are filed to report insider transactions by company officers and directors, and any beneficial owners of more than ten percent of a company's shares. Form 3 is the initial report that must be filed when a person becomes an officer, director, or beneficial owner. Form 4 reports are used to report changes in ownership, while the Form 5 report is used for reporting transactions that should have been reported earlier in a Form 4 filing.